Skip to content
Search

Latest Stories

Revealed: Top 5 reasons why Brits avoid visiting doctors

Revealed: Top 5 reasons why Brits avoid visiting doctors

While self-testing can alleviate pressure on the NHS, more than a quarter of Brits mistakenly believe at-home tests require a prescription from a medical professional

Long appointment wait times, embarrassment, and lack of trust are causing thousands of Brits to avoid visiting doctors, according to new research by Newfoundland Diagnostics.


With 1 in 4 individuals resorting to A&E due to the lack of available GP appointments, which adds to the NHS burden, the medical self-testing brand believes that educating the nation on at-home testing can help ease the strain on the health service.

The research revealed the top five reasons why Brits avoid visiting doctors for medical testing:

  1. Appointments taking too long to book (28 per cent)
  2. Embarrassment around their illnesses (15 per cent)
  3. Preference for at-home testing (12 per cent)
  4. Not having time (10 per cent)
  5. Lack of trust in the NHS or their GP (7 per cent)

The research team cautioned that delaying care can worsen conditions, resulting in more severe cases that place greater strain on the NHS.

Newfoundland Diagnostics, a leading UK provider of diagnostic tests and medical devices, aims to alleviate this burden by encouraging nationwide testing. The organisation believes that by enabling individuals to easily gather data at home, self-testing can help reduce unnecessary doctor visits and ensure patients are well-informed when seeking quality care.

While self-testing became popular during the COVID-19 pandemic, there remain significant educational gaps that need to be addressed, the company stated.

Newfoundland Diagnostics’ research also found that over a quarter of Brits believe that at-home tests require a prescription from a medical professional, even though these tests are readily available in major supermarkets and pharmacies across the UK.

This misconception is even more prevalent among men, with more than 1 in 3 believing that self-tests cannot be purchased over the counter, compared to 23 per cent of women.

The research further indicates that younger Brits, particularly those aged 16-24, need better education on healthcare access, as nearly half of them think at-home tests must be prescribed, compared to less than 1 in 5 of those 55 and older.

"It’s surprising how many across the country believe that at-home testing is inaccessible despite their ubiquity during the pandemic,” said Frederick Manduca, co-founder of Newfoundland Diagnostics.

Meanwhile, renowned GP and broadcaster Dr Hilary Jones has joined the company in an advisory role to educate the nation on testing at home to help ease the strain on the NHS.

He believes self-testing can help overcome the barriers preventing people from seeking medical care.

Dr Jones said: "At-home testing has the potential to be a game-changer for easing the strain on our NHS, but we need more Brits to embrace self-testing.

"By empowering people to routinely monitor their health and identify issues early, we can significantly reduce unnecessary GP and A&E visits for conditions that could be caught sooner through self-testing. This frees up critical medical resources for those most in need of urgent care.”

Dr Jones elaborated that self-tests provide patients with key diagnostic information, which they can share with their doctor for more informed, effective treatment plans.

He highlighted that detecting issues like high cholesterol, fertility problems or potential cancers at an earlier stage leads to better health outcomes and could potentially saving lives.

Manduca expressed that Dr. Hilary's advisory role would be invaluable in empowering the nation to embrace their easy-to-use, affordable at-home tests as “a pathway to accessible healthcare”, emphasising that early identification can be life-saving.

More For You

RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less